Pennsylvania Capital Management’s Pfizer PFE Stock Holding History

Pennsylvania Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,124	Closed	-$250K	–	89
2023 Q1	$250K	Hold	6,124	–	–	0.12%	74
2022 Q4	$291K	Buy	6,124 +1,179	+24%	+$56.5K	0.15%	76
2022 Q3	$216K	Hold	4,945	–	–	0.12%	73
2022 Q2	$259K	Buy	4,945 +300	+6%	+$15.3K	0.14%	66
2022 Q1	$240K	Sell	4,645 -9,800	-68%	-$508K	0.1%	74
2021 Q4	$853K	Buy	+14,445	New	+$716K	0.29%	46
2020 Q3	–	Sell	-7,439	Closed	-$231K	–	110
2020 Q2	$231K	Buy	+7,439	New	+$253K	0.12%	101

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pennsylvania Capital Management's PFE Position: Q2 2023 in Review

Pennsylvania Capital Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 6,124 shares — an estimated $250K sold.

Pennsylvania Capital Management first reported a position in PFE in Q2 2020 and held it in 7 quarters. The position peaked at $853K in Q4 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Pennsylvania Capital Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Pennsylvania Capital Management sold 6,124 Pfizer shares in Q2 2023, an estimated $250K.
Pennsylvania Capital Management first reported a position in Pfizer in Q2 2020 and held it in 7 quarters.
Pennsylvania Capital Management's Pfizer position peaked at $853K in Q4 2021.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Pennsylvania Capital Management's 13F filing for Q2 2023, filed 18 Jul 2023.